Menú

EMAP
Estudis en Medicaments en Atenció Primària (EMAP)

Group leader
avatar_investigadors.jpg
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Projectes

Group projects

A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00211-24
  • Start year: 2024

Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research (ADEPT). Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and adverse pregnancy, neonatal and child outcomes

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00239-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Efectividad de la administración de fosfomicina trometamol monodosis versus dos dosis en mujeres con infección urinaria baja no complicada

  • Principal investigators: Rosa Morros Pedrós
  • Code: 4RNC-0-00087-25
  • Start year: 2025

Estudio de utilización de medicamentos para el tratamiento de la insuficiencia cardíaca (IDIAP-IC-2025)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00095-25
  • Start year: 2025

Estudi d’utilització de medicaments per al tractament de la malaltia pulmonar obstructiva crònica a Catalunya

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00124-25
  • Start year: 2025